P/B
—
Scienture Holdings
Scienture Holdings Inc is a comprehensive health services and pharmaceutical product company. The group focused on providing value to patients and caregivers by offering novel specialty products to satisfy unmet market needs and optimize the prescription journey and patient engagement in the U.S.
Scienture Holdings Inc is a comprehensive health services and pharmaceutical product company. The group focused on providing value to patients and caregivers by offering novel specialty products to satisfy unmet market needs and optimize the prescription journey and patient engagement in the U.S.
$15M
Market Cap • 9/11/2026
2005
(21 years)
Founded
2008
(18 years ago)
IPO
NASDAQ
Listing Exchange
United States
Country
Valuation
P/S
18,2
P/EBITDA
—
P/OCF
—
P/FCF
—
P/E
—
BVPS
—
EPS
—
Market Cap
Market Cap
15M
EV
17,5M
EV/Revenue
21,3
EV/EBITDA
-0,5
EV/EBIT
-0,4
Payout
Dividend Per Share
0
Dividend Yield
0%
Buyback Yield
0%
Total Yield
0%
Dividend Yield 5Y
14,6%
Payout
0%
Profitability
Gross Margin
87,7%
EBITDA Margin
—
EBIT Margin
—
Net Margin
—
D&A/EBITDA
0%
R&D/Revenue
304,2%
Capex/Revenue
0%
Capex/D&A
0%
Capex/OCF
0%
SBC/OCF
—
% PPE
0%
% Goodwill
0%
ROE
—
ROIC
—
Growth
CAGR Revenue 5Y
-42,7%
CAGR Op. Income 5Y
49,5%
CAGR Net Income 5Y
67,7%
CAGR EPS 5Y
-26,9%
Leverage
N.D./EBITDA
—
Debt/Equity
0%
Current Ratio
3
Quick Ratio
2,8
Interest Coverage
—
Premium
- Unrestricted access
- Unlimited data history
- Analysis videos
- Quarterly highlights
- Customizable financials table
- Ranking
- Discussions
...and much more!